hemo-logoThe February 10th edition of the CHS E-Liaison included news of the 2 additional patient support programs for accessing treatments for hepatitis C through the Hepatitis C January 1, 1986 — July 1, 1990 Class Actions Settlement.  These programs offered by companies that make and sell hepatitis C medications offer assistance by providing drugs upfront to the 86-90 claimants through their speciality pharmacy. Once the 86-90 plan issues the reimbursement cheques to the patients for their treatment, they, in turn, must reimburse the pharmacy directly.

Last fall, the CHS disseminated information about the first program to offer this service, the Momentum Program by Gilead. Since then , AbbVie has launched their own program: AbbVie Care, as well as Janssen: Galexos: BioAdvance Patient Support Program.

We now have the possibility of eradicating this disease in our bleeding disorder population thanks to a variety of treatment options!

The CHS website has an updated page which you can consult and share:  www.hemophilia.ca/en/hcv-hiv/hcv-treatment-support-for-1986-1990-claimants

CHS has created  a new updated bilingual brochure. We should have copies in the Chapter office soon as well as all the Hemophilia Treatment Centres. You can see the brochures:

Accessing Hep C Treatment English   Accessing Hep C Treatment French